《大行報告》大和料京東-SW(09618.HK)次季業績穩健 評級「買入」
大和發表評級報告,料京東-SW(09618.HK)次季業績穩健,其零售銷售按年升3%,主要是在「618購物節」期間被壓抑需求及3P商品交易總額增長強勁,並預料次季商品交易總額(GMV)按年升9%,當中3C產品、家電及服裝或錄得雙位數增長,同時快速消費品因上年基數高,令次季表現受到拖累。
該行預料,京東零售次季營運利潤率按年持平,而京東集團次季淨利潤率按年增長52個基點,主要是新業務虧損減少。同時該行預計,集團第三季總收入按年升4.4%,而第四季則按年升5.1%。
該行表示,將公司在2023年至25年盈利預測大致上維持不變,並維持其目標價為216元,以及其評級為「買入」。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.